Trajan and University of Tasmania Succeeds with ARC Application for $2.1 M from Australian Government

Trajan and University of Tasmania Succeeds with ARC Application for $2.1 M from Australian Government

December 20, 2013

Trajan Scientific and Medical (Trajan) is pleased to announce that the Australian Research Council (ARC) has selected the University of Tasmania (UTAS) and Trajan’s proposal to create an ARC Training Centre for Portable Analytical Separation Technologies.

The program will see the Australian Government committing more than A$2.1 million funding from 2014 over three years, to establish and provide ongoing support to the Training Centre. The partnership of Trajan and UTAS combines industry knowledge and research to innovate in product design, development and manufacturing techniques.

The ARC’s Industrial Transformation Training Centres Scheme aims to foster close partnerships between university-based researchers and other research end-users to provide innovative Higher Degree by Research (HDR) and postdoctoral training for the end-user focused research industries vital to Australia's future.

Trajan encompasses a group of companies including SGE Analytical Science, Grale HDS and SciMed Precision with over 300 staff worldwide, and customers in over 100 countries.

Trajan’s focus is on developing and commercializing technologies that enable analytical systems to be more selective, sensitive and specific for biological, environmental or food related measurements, especially those that can lead to portability, miniaturization and affordability.

Stephen Tomisich, Trajan’s Chief Executive Officer said, “Developing the new ARC Training Centre for Portable Analytical Separation Technologies with the University of Tasmania, is aligned with Trajan’s vision to engage in partnerships to deliver breakthrough solutions to the world.

“The Separation Science team at the University of Tasmania are world leaders and we are excited to be building our partnership with them.

“Our passion is to have a positive impact on the world of analytical and medical science; and this collaboration propels us towards that goal.”

Related News
Life Scientist - Funding for plant energy biology and analytical separation technologies




Also in News

Trajan completes ISO 9001 recertification
Trajan completes ISO 9001 recertification

July 14, 2021

Trajan Scientific and Medical has successfully completed a 3-year ISO 9001:2015 recertification at our Ringwood global headquarters this week, cementing the importance that we place over quality management and continuous improvement for ourselves and all stakeholders.

Read More

Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth
Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth

May 17, 2021

Global analytical science and device company Trajan Group Holdings Limited (Trajan or the Company) has launched a $90 million IPO to support the next phase of accelerated growth.

Read More

Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare
Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare

April 16, 2021

Trajan Scientific and Medical (Trajan) has completed the acquisition of the MyHealthTest blood testing service for an undisclosed sum. The acquisition further boosts Trajan’s ability to deliver analytical measurement services to society at a time when preventative healthcare strategies are becoming increasingly important.

Read More